PGEN Competitors & Alternatives
Compare Precigen Inc with similar stocks in the same industry
Biotechnology
PGEN
Main Stock$5.40
Tradestie Score
57
Market Cap
$1.18B
Revenue Growth
16.3%
Analyst Upside
+130.6%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$16.70
|
$2.02B | 49.1 | 53 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$15.50
|
$2.01B | - | 57 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$37.53
|
$1.97B | - | 61 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.85
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$96.38
|
$1.92B | - | 54 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$75.54
|
$1.90B | 435.5 | 59 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$39.51
|
$1.84B | - | 56 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.99
|
$1.81B | - | 64 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.03
|
$1.78B | - | 58 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.33
|
$1.78B | - | 58 | Compare |
More PGEN Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry